/ Print /

Health/Disease Strategy

Views split on population health benefitsViews on the importance of population health differ depending on how you interact with patients, says the NEJM Care Redesign survey.
Racial disparity in breast cancer mortality linked to genesUnderstanding genetic variations and tumor differences in black women with breast cancer could lead to personalized diagnosis and treatment.
How to make diabetes control easier for patientsA real-world study of type 2 diabetes patients by Milliman has surprising findings on glycemic control and diabetes medication adherence.
How population, community health goals overlapA new study found that distinguishing between population health and community health strategies can help health organizations define clear goals and earmark the right resources to accomplish them.
Longer-term bundled payments prove beneficialA new study finds that expanding the way bundled payments are utilized could make a positive impact for patients and on costs.
Six barriers to prescribing PCSK9 inhibitorsA National Lipid Association survey has interesting findings on the prescription approval process for PCSK9 inhibitors.
Pharmaceutical pipeline: Top 4 conditions to watch
Pharmaceutical pipeline: Top 4 conditions to watchAlthough drug spend is increasing for inflammatory conditions, diabetes, and oncology, there are some promising developments in the pipeline.
Top three patient care essentialsOak Street Health co-founder tells AHIP 2017 attendees about its novel approach to patient care.
Why you need to pay attention to precision medicineDigital health pioneer Eric Topol talks about plans for a four-year precision medicine study at AHIP 2017.
Patients with complex needs require a custom approachAHIP 2017: Older adults with complex chronic conditions require payers to “look under the hood.”